EyeControl
PrivateLast Round
Grant
May 1, 2024
Total Funding Raised
$13.3M
Company Overview
EyeControl is a health tech company that develops an AI-powered, wearable eye-tracking platform designed to enable communication for mechanically ventilated patients and individuals with locked-in syndrome.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, NLP & Conversational AI, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EyeControl Comparables
Compare EyeControl with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Irisbond | 81% | |
| Eyegaze Inc. | 80% | |
| Control Bionics Ltd | 78% | |
EyeControl Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2024 | ||||
| Grant | Jan 1, 2024 | ||||
| Series A | Aug 12, 2020 | ||||
| Grant | Aug 12, 2020 | ||||
| Grant | Feb 29, 2020 | ||||
VC Round | Oct 21, 2019 |
Key People
Founding team and executive leadership
EyeControl Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Connecticut Innovations | VC Round, Series A |
| a2 Collective | Grant |
| Menomadin Foundation | Series A |
| Rimonci | Series A |
| Zora Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2024
$200K grant round from Grow with Google.
- Jan 1, 2024
Received grant funding from a2 Collective.
EyeControl Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EyeControl's valuation, stock price, and market status.